GLAUKOS Corp (GKOS) stock
GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 7/30219% above fair value
$245.72−0.31 (-0.13%)
Close on Nov 13, 2026Market cap $14.55BP/E –Yield –
Glaukos cash
Cash and short-term investments held at the end of each period.
Glaukos's cash was $162.33M at Sep 30, 2026. For fiscal 2025 it was $90.81M, down 47.9% from the year before. Over ten years it grew -0.0% a year on average. The highest annual figure on record is $423.50M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.81M | -47.9% |
| FY2024 | Dec 31, 2024 | $174.36M | +86.5% |
| FY2023 | Dec 31, 2023 | $93.47M | -26.2% |
| FY2022 | Dec 31, 2022 | $126.60M | -70.1% |
| FY2021 | Dec 31, 2021 | $423.50M | +2.3% |
| FY2020 | Dec 31, 2020 | $413.90M | +125.8% |
| FY2019 | Dec 31, 2019 | $183.30M | +22.8% |
| FY2018 | Dec 31, 2018 | $149.30M | +25.5% |
| FY2017 | Dec 31, 2017 | $119.00M | +24.2% |
| FY2016 | Dec 31, 2016 | $95.80M | +5.2% |
| FY2015 | Dec 31, 2015 | $91.10M | +3854.0% |
| FY2014 | Dec 31, 2014 | $2.30M | -65.8% |
| FY2013 | Dec 31, 2013 | $6.73M | +288.5% |
| FY2012 | Dec 31, 2012 | $1.73M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $162.33M | +59.0% |
| Q2 FY2026 | Jun 30, 2026 | $114.49M | +9.4% |
| Q1 FY2026 | Mar 31, 2026 | $104.25M | -12.4% |
| Q4 FY2025 | Dec 31, 2025 | $90.81M | -47.9% |
| Q3 FY2025 | Sep 30, 2025 | $102.08M | -2.7% |
| Q2 FY2025 | Jun 30, 2025 | $104.65M | +43.7% |
| Q1 FY2025 | Mar 31, 2025 | $118.99M | +146.1% |
| Q4 FY2024 | Dec 31, 2024 | $174.36M | +86.5% |
| Q3 FY2024 | Sep 30, 2024 | $104.88M | -8.6% |
| Q2 FY2024 | Jun 30, 2024 | $72.81M | -27.7% |
| Q1 FY2024 | Mar 31, 2024 | $48.35M | -42.1% |
| Q4 FY2023 | Dec 31, 2023 | $93.47M | -26.2% |
| Q3 FY2023 | Sep 30, 2023 | $114.79M | +1.5% |
| Q2 FY2023 | Jun 30, 2023 | $100.67M | -9.9% |
| Q1 FY2023 | Mar 31, 2023 | $83.48M | -27.8% |
| Q4 FY2022 | Dec 31, 2022 | $126.60M | -70.1% |
| Q3 FY2022 | Sep 30, 2022 | $113.10M | -7.7% |
| Q2 FY2022 | Jun 30, 2022 | $111.68M | -12.6% |
| Q1 FY2022 | Mar 31, 2022 | $115.62M | +9.0% |
| Q4 FY2021 | Dec 31, 2021 | $423.50M | +2.3% |
| Q3 FY2021 | Sep 30, 2021 | $122.55M | +35.7% |
| Q2 FY2021 | Jun 30, 2021 | $127.71M | -53.8% |
| Q1 FY2021 | Mar 31, 2021 | $106.04M | +68.5% |
| Q4 FY2020 | Dec 31, 2020 | $413.90M | +125.8% |
| Q3 FY2020 | Sep 30, 2020 | $90.32M | +86.6% |
| Q2 FY2020 | Jun 30, 2020 | $276.30M | +465.7% |
| Q1 FY2020 | Mar 31, 2020 | $62.94M | +48.1% |
| Q4 FY2019 | Dec 31, 2019 | $183.30M | +22.8% |
| Q3 FY2019 | Sep 30, 2019 | $48.42M | +29.9% |
| Q2 FY2019 | Jun 30, 2019 | $48.84M | +95.8% |
| Q1 FY2019 | Mar 31, 2019 | $42.49M | +172.6% |
| Q4 FY2018 | Dec 31, 2018 | $149.30M | +25.5% |
| Q3 FY2018 | Sep 30, 2018 | $37.28M | +93.0% |
| Q2 FY2018 | Jun 30, 2018 | $24.94M | +86.5% |
| Q1 FY2018 | Mar 31, 2018 | $15.59M | +80.2% |
| Q4 FY2017 | Dec 31, 2017 | $119.00M | +24.2% |
| Q3 FY2017 | Sep 30, 2017 | $19.32M | – |
| Q2 FY2017 | Jun 30, 2017 | $13.37M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.65M | – |
| Q4 FY2016 | Dec 31, 2016 | $95.80M | – |
See a number that looks wrong?